Levetiracetam Stada (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which plays a crucial role in regulating neurotransmitter release. By modulating this process, the drug stabilises neuronal activity and prevents the excessive firing that leads to seizure events.

The appropriate dose of Levetiracetam Stada is determined individually by a qualified prescriber based on the patient’s age, weight, renal function, and seizure type. Dosage adjustments are made to achieve optimal seizure control while minimising side effects.

Safety data for levetiracetam in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks and discuss alternative options when appropriate. Women who are pregnant, planning pregnancy, or breastfeeding should consult their physician before using this medication.

To place an order, submit an inquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancing agents such as valproate. It is generally well tolerated, has fewer drug‑enzyme interactions, and can be used as monotherapy or adjunctive therapy depending on the clinical scenario.

Levetiracetam Stada should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Levetiracetam Stada is taken orally, usually with or without food, as directed by the prescribing clinician. The tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed.

Serious adverse reactions can include severe allergic responses such as Stevens‑Johnson syndrome, significant mood changes like depression or suicidal thoughts, and rare hematologic abnormalities. Patients should seek immediate medical attention if they experience rash, swelling, mood disturbances, or unexplained bruising.

Patients with known hypersensitivity to levetiracetam or any component of the formulation should not use the product. Caution is also advised for individuals with severe renal impairment, uncontrolled psychiatric conditions, or those taking medications that may cause major interactions without appropriate monitoring.